Edwards Lifesciences Corp (EW)

$76.10 -0.43 (-0.56%)
Market Cap 44.93B
Revenue (ttm) 5.44B
Net Income (ttm) 4.17B
EPS (ttm) N/A
PE Ratio 29.90
Forward PE 30.64
Profit Margin 76.75%
Debt to Equity Ratio 0.06
Volume 3,165,600
Avg Vol 4,260,106
Day's Range N/A - N/A
Shares Out 587.10M
Stochastic %K 62%
Beta 1.05
Analysts Sell
Price Target $86.78

Company Profile

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. The company offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband brands. I...

Industry: Medical Devices
Sector: Healthcare
Phone: 949 250 2500
Address:
One Edwards Way, Irvine, United States
victorgn
victorgn Oct. 24 at 3:10 PM
$EW up up and away .. to $82
0 · Reply
victorgn
victorgn Oct. 24 at 1:46 PM
$EW to $82 and beyond ..
0 · Reply
victorgn
victorgn Oct. 23 at 5:56 PM
$EW going to explode upwards to $78
0 · Reply
SuperGreenToday
SuperGreenToday Oct. 23 at 1:42 AM
$EW Share Price: $76.82 Contract Selected: Feb 20, 2026 $80 Calls Buy Zone: $4.08 – $5.04 Target Zone: $7.17 – $8.77 Potential Upside: 66% ROI Time to Expiration: 120 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
victorgn
victorgn Oct. 22 at 5:49 PM
$EW tgt: $78
0 · Reply
GettnFibbywIT
GettnFibbywIT Oct. 22 at 5:27 PM
$EW $XLK $IHI So far, 10/22 purgatory.....
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 22 at 6:03 AM
Enter: $EW NOV 21 2025 $78 CALLS Buy in Price: $3.20 - $3.30 Take Profit: $6.69 Stop Bleeding: $2.82 ROI Potential: 109% Exit Within: 3 Weeks https://moneygroup.us/alerts
0 · Reply
GettnFibbywIT
GettnFibbywIT Oct. 21 at 5:53 PM
$EW $XLK $IHI Edwards Lifesciences (EW) / Daily :
0 · Reply
RunnerSignals
RunnerSignals Oct. 21 at 3:39 AM
$AVTR $EW $GPOR $HTO.X $ORC crossing above 200-day MAs! Golden crosses everywhere you look
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 20 at 4:27 AM
Enter: $EW NOV 21 2025 $75 CALLS Buy in Price: $3.45 - $3.60 Take Profit: $7.52 Stop Bleeding: $3.04 ROI Potential: 118% Exit Within: 2 Weeks https://moneygroup.us/alerts
0 · Reply
Latest News on EW
EW Investor News: Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Edwards Lifesciences Corporation – EW

Oct 24, 2025, 3:56 PM EDT - 22 hours ago

EW Investor News: Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Edwards Lifesciences Corporation – EW

Edwards Lifesciences to Host Earnings Conference Call on October 30, 2025

Oct 23, 2025, 7:05 AM EDT - 2 days ago

Edwards Lifesciences to Host Earnings Conference Call on October 30, 2025

Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Edwards Lifesciences Corporation - EW

Oct 22, 2025, 6:31 PM EDT - 2 days ago

Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Edwards Lifesciences Corporation - EW

EW Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Edwards Lifesciences Corporation – EW

Oct 16, 2025, 6:00 PM EDT - 8 days ago

EW Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Edwards Lifesciences Corporation – EW

Edwards Lifesciences: Inflection Incoming, But When?

Oct 14, 2025, 2:36 PM EDT - 10 days ago

Edwards Lifesciences: Inflection Incoming, But When?

Updated ESC/EACTS Guidelines Mark Advancement in Structural Heart Disease Care

Aug 29, 2025, 9:09 AM EDT - 2 months ago

Updated ESC/EACTS Guidelines Mark Advancement in Structural Heart Disease Care

Edwards Lifesciences Announces $500 Million Accelerated Share Repurchase

Aug 19, 2025, 4:15 PM EDT - 2 months ago

Edwards Lifesciences Announces $500 Million Accelerated Share Repurchase

Edwards Lifesciences Corporation Investors: Company Investigated by the Portnoy Law Firm

Aug 14, 2025, 4:16 PM EDT - 2 months ago

Edwards Lifesciences Corporation Investors: Company Investigated by the Portnoy Law Firm

Baron Capital's Top Health Care Stock Picks And Misses From Q2 2025

Aug 7, 2025, 9:45 PM EDT - 2 months ago

Baron Capital's Top Health Care Stock Picks And Misses From Q2 2025

ACLX BSX EXAS GH ISRG LLY MASI

JenaValve Responds to FTC's Action Against Proposed Edwards Lifesciences Acquisition

Aug 6, 2025, 2:17 PM EDT - 2 months ago

JenaValve Responds to FTC's Action Against Proposed Edwards Lifesciences Acquisition

FTC seeks to block Edwards Lifesciences' acquisition of JenaValve

Aug 6, 2025, 1:41 PM EDT - 2 months ago

FTC seeks to block Edwards Lifesciences' acquisition of JenaValve

Edwards Lifesciences Comments on FTC's Action to Block Proposed Acquisition of JenaValve

Aug 6, 2025, 1:40 PM EDT - 2 months ago

Edwards Lifesciences Comments on FTC's Action to Block Proposed Acquisition of JenaValve

Edwards Lifesciences Stock: Likely To See Sluggish Price Action Through 2027

Aug 6, 2025, 12:20 PM EDT - 2 months ago

Edwards Lifesciences Stock: Likely To See Sluggish Price Action Through 2027

10 stocks favored to gain up to 30% in a sector that has missed this year's rally

Jul 31, 2025, 9:52 AM EDT - 3 months ago

10 stocks favored to gain up to 30% in a sector that has missed this year's rally

BSX CAH DXCM ISRG LLY PODD SYK

Edwards Lifesciences Lifts 2025 Outlook On Strong First Half Performance

Jul 25, 2025, 1:49 PM EDT - 3 months ago

Edwards Lifesciences Lifts 2025 Outlook On Strong First Half Performance

Edwards Lifesciences Analysts Increase Their Forecasts After Stronger-Than-Expected Q2 Results

Jul 25, 2025, 9:53 AM EDT - 3 months ago

Edwards Lifesciences Analysts Increase Their Forecasts After Stronger-Than-Expected Q2 Results

Edwards Lifesciences Corporation (EW) Q2 2025 Earnings Call Transcript

Jul 24, 2025, 11:07 PM EDT - 3 months ago

Edwards Lifesciences Corporation (EW) Q2 2025 Earnings Call Transcript

Edwards Lifesciences raises annual sales forecast on strong demand for heart devices

Jul 24, 2025, 4:53 PM EDT - 3 months ago

Edwards Lifesciences raises annual sales forecast on strong demand for heart devices

Edwards Lifesciences Reports Second Quarter Results

Jul 24, 2025, 4:15 PM EDT - 3 months ago

Edwards Lifesciences Reports Second Quarter Results

Five years after COVID, pharma shares languish in US policy limbo

Jul 23, 2025, 9:57 AM EDT - 3 months ago

Five years after COVID, pharma shares languish in US policy limbo

ABBV ABT ALNY AZN LLY MRK NVO

Edwards Lifesciences to Host Earnings Conference Call on July 24, 2025

Jul 18, 2025, 7:05 AM EDT - 3 months ago

Edwards Lifesciences to Host Earnings Conference Call on July 24, 2025

Edwards Lifesciences: With A Heart Beating Strong And Steady

Jun 4, 2025, 2:11 PM EDT - 5 months ago

Edwards Lifesciences: With A Heart Beating Strong And Steady

Prompt Intervention for Severe Aortic Stenosis Patients Demonstrates Lower Healthcare Costs, Improved Clinical Outcomes

May 22, 2025, 2:30 AM EDT - 5 months ago

Prompt Intervention for Severe Aortic Stenosis Patients Demonstrates Lower Healthcare Costs, Improved Clinical Outcomes

Trade Tracker: Bill Baruch buys Edwards Lifesciences

May 19, 2025, 2:13 PM EDT - 5 months ago

Trade Tracker: Bill Baruch buys Edwards Lifesciences

Edwards Lifesciences to Present at the BofA Securities 2025 Health Care Conference

May 6, 2025, 7:05 AM EDT - 6 months ago

Edwards Lifesciences to Present at the BofA Securities 2025 Health Care Conference

Edwards TAVR Receives FDA Approval for Patients With Asymptomatic Severe Aortic Stenosis

May 1, 2025, 8:00 AM EDT - 6 months ago

Edwards TAVR Receives FDA Approval for Patients With Asymptomatic Severe Aortic Stenosis

Edwards Lifesciences Stock Earns Analyst Upgrade As Growth Outlook Brightens

Apr 24, 2025, 2:42 PM EDT - 6 months ago

Edwards Lifesciences Stock Earns Analyst Upgrade As Growth Outlook Brightens

Edwards Lifesciences Corporation (EW) Q1 2025 Earnings Call Transcript

Apr 23, 2025, 9:35 PM EDT - 6 months ago

Edwards Lifesciences Corporation (EW) Q1 2025 Earnings Call Transcript

Edwards Lifesciences raises 2025 sales forecast after robust quarter

Apr 23, 2025, 5:43 PM EDT - 6 months ago

Edwards Lifesciences raises 2025 sales forecast after robust quarter

Edwards Lifesciences Reports First Quarter Results

Apr 23, 2025, 4:15 PM EDT - 6 months ago

Edwards Lifesciences Reports First Quarter Results

Eight-Year Data Confirm Long-Term Durability of Edwards' RESILIA Tissue

Apr 18, 2025, 8:00 AM EDT - 6 months ago

Eight-Year Data Confirm Long-Term Durability of Edwards' RESILIA Tissue

Edwards Lifesciences to Host Earnings Conference Call on April 23, 2025

Apr 16, 2025, 7:05 AM EDT - 6 months ago

Edwards Lifesciences to Host Earnings Conference Call on April 23, 2025

Edwards SAPIEN M3 Receives CE Mark, Becoming World's First Transfemoral Transcatheter Mitral Valve Replacement System

Apr 14, 2025, 8:00 AM EDT - 6 months ago

Edwards SAPIEN M3 Receives CE Mark, Becoming World's First Transfemoral Transcatheter Mitral Valve Replacement System

New Data Confirm Rapid, Unpredictable Progression of Severe Aortic Stenosis and Need for Urgent Referral and Evaluation of Patients

Mar 31, 2025, 2:00 PM EDT - 7 months ago

New Data Confirm Rapid, Unpredictable Progression of Severe Aortic Stenosis and Need for Urgent Referral and Evaluation of Patients

Edwards Lifesciences: Double-Digit Top Line And EPS Growth Ahead

Mar 22, 2025, 11:51 PM EDT - 7 months ago

Edwards Lifesciences: Double-Digit Top Line And EPS Growth Ahead

Scaling its Investment Platform in Minimally Invasive Care, Intuitive Ventures Appoints Terri Burke as Senior Partner and Ross Jaffe as Venture Advisor

Mar 6, 2025, 8:00 AM EST - 8 months ago

Scaling its Investment Platform in Minimally Invasive Care, Intuitive Ventures Appoints Terri Burke as Senior Partner and Ross Jaffe as Venture Advisor

Edwards Lifesciences to Present at the TD Cowen 45th Annual Health Care Conference

Feb 25, 2025, 7:05 AM EST - 8 months ago

Edwards Lifesciences to Present at the TD Cowen 45th Annual Health Care Conference

Heart Devices-Focused Edwards Lifesciences Confident in 2025 Outlook, Analyst Sees Long-Term Strength

Feb 12, 2025, 2:51 PM EST - 9 months ago

Heart Devices-Focused Edwards Lifesciences Confident in 2025 Outlook, Analyst Sees Long-Term Strength

Edwards Lifesciences Corporation (EW) Q4 2024 Earnings Call Transcript

Feb 11, 2025, 9:46 PM EST - 9 months ago

Edwards Lifesciences Corporation (EW) Q4 2024 Earnings Call Transcript

Edwards Lifesciences beats profit estimate on strength in heart devices

Feb 11, 2025, 4:19 PM EST - 9 months ago

Edwards Lifesciences beats profit estimate on strength in heart devices

Edwards Lifesciences Reports Fourth Quarter Results

Feb 11, 2025, 4:15 PM EST - 9 months ago

Edwards Lifesciences Reports Fourth Quarter Results

Edwards Lifesciences to Host Earnings Conference Call on February 11, 2025

Feb 4, 2025, 7:05 AM EST - 9 months ago

Edwards Lifesciences to Host Earnings Conference Call on February 11, 2025

Edwards Lifesciences Is Poised For Solid Growth In 2025—Analyst Highlights TAVR Growth, Margin Expansion

Jan 30, 2025, 2:21 PM EST - 9 months ago

Edwards Lifesciences Is Poised For Solid Growth In 2025—Analyst Highlights TAVR Growth, Margin Expansion

Wedgewood Partners: Q4 And 2024 Top Performers And Detractors

Jan 16, 2025, 8:00 AM EST - 10 months ago

Wedgewood Partners: Q4 And 2024 Top Performers And Detractors

BKNG CDW GOOG GOOGL META MSI ODFL

Edwards Lifesciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Jan 7, 2025, 7:05 AM EST - 10 months ago

Edwards Lifesciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference

4 Strong Stock Charts For 2025 (Technical Analysis)

Dec 30, 2024, 12:00 PM EST - 10 months ago

4 Strong Stock Charts For 2025 (Technical Analysis)

DRI JBL KR

EW FINAL DEADLINE FRIDAY: Edwards Lifesciences Investors have Until Tomorrow December 13 before Expiration of Court Deadline - Contact BFA Law

Dec 12, 2024, 3:18 PM EST - 11 months ago

EW FINAL DEADLINE FRIDAY: Edwards Lifesciences Investors have Until Tomorrow December 13 before Expiration of Court Deadline - Contact BFA Law

victorgn
victorgn Oct. 24 at 3:10 PM
$EW up up and away .. to $82
0 · Reply
victorgn
victorgn Oct. 24 at 1:46 PM
$EW to $82 and beyond ..
0 · Reply
victorgn
victorgn Oct. 23 at 5:56 PM
$EW going to explode upwards to $78
0 · Reply
SuperGreenToday
SuperGreenToday Oct. 23 at 1:42 AM
$EW Share Price: $76.82 Contract Selected: Feb 20, 2026 $80 Calls Buy Zone: $4.08 – $5.04 Target Zone: $7.17 – $8.77 Potential Upside: 66% ROI Time to Expiration: 120 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
victorgn
victorgn Oct. 22 at 5:49 PM
$EW tgt: $78
0 · Reply
GettnFibbywIT
GettnFibbywIT Oct. 22 at 5:27 PM
$EW $XLK $IHI So far, 10/22 purgatory.....
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 22 at 6:03 AM
Enter: $EW NOV 21 2025 $78 CALLS Buy in Price: $3.20 - $3.30 Take Profit: $6.69 Stop Bleeding: $2.82 ROI Potential: 109% Exit Within: 3 Weeks https://moneygroup.us/alerts
0 · Reply
GettnFibbywIT
GettnFibbywIT Oct. 21 at 5:53 PM
$EW $XLK $IHI Edwards Lifesciences (EW) / Daily :
0 · Reply
RunnerSignals
RunnerSignals Oct. 21 at 3:39 AM
$AVTR $EW $GPOR $HTO.X $ORC crossing above 200-day MAs! Golden crosses everywhere you look
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 20 at 4:27 AM
Enter: $EW NOV 21 2025 $75 CALLS Buy in Price: $3.45 - $3.60 Take Profit: $7.52 Stop Bleeding: $3.04 ROI Potential: 118% Exit Within: 2 Weeks https://moneygroup.us/alerts
0 · Reply
Misty_Sage4069
Misty_Sage4069 Oct. 19 at 10:25 AM
$EW Beautiful consolidation breakout!
0 · Reply
GoodLife66
GoodLife66 Oct. 19 at 6:16 AM
$EW took some shares here Friday chart was looking nice.
0 · Reply
GlobalMarketBulletin
GlobalMarketBulletin Oct. 19 at 5:41 AM
$EW Edward Lifesciences' EPS, beat last quarter by 8.06%. It's momentum continues as analysts Predict Another Beat. https://biotechhealthx.com/biotech-news/edwards-lifesciences-ew-set-to-report-1-50b-in-q3-sales/
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 19 at 3:21 AM
Enter: $EW NOV 21 2025 $75 CALLS Buy in Price: $3.45 - $3.60 Take Profit: $8.14 Stop Bleeding: $3.04 ROI Potential: 136% Exit Within: 3 Weeks https://moneygroup.us/alerts
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 18 at 7:46 AM
Enter: $EW NOV 21 2025 $75 CALLS Buy in Price: $3.58 - $3.70 Take Profit: $8.02 Stop Bleeding: $3.15 ROI Potential: 124% Exit Within: 3 Weeks https://moneygroup.us/alerts
0 · Reply
ZacksResearch
ZacksResearch Oct. 17 at 12:52 PM
$EW gearing up for Q3 earnings — can it keep beating estimates? 📈 With a Zacks Rank #3 and +0.47% Earnings ESP, the setup looks promising. TAVR segment expected to shine with strong performance in the U.S. and Europe, while TMTT gains global traction with PASCAL. Full earnings preview here 👉 https://www.zacks.com/stock/news/2770899/robust-tavr-growth-to-drive-edwards-lifesciences-q3-earnings?cid=sm-stocktwits-2-2770899-body-16536&ADID=SYND_STOCKTWITS_TWEET_2_2770899_BODY_16536
0 · Reply
ZacksResearch
ZacksResearch Oct. 17 at 11:52 AM
$EW setting up for a strong Q3 beat? 🚀 Robust TAVR growth and expanding valve therapies are expected to drive results, even as EPS estimates tick lower — a bullish setup worth noting. Full breakdown on the Q3 outlook here 👉 https://www.zacks.com/stock/news/2770899/robust-tavr-growth-to-drive-edwards-lifesciences-q3-earnings?cid=sm-stocktwits-2-2770899-teaser-16535&ADID=SYND_STOCKTWITS_TWEET_2_2770899_TEASER_16535
0 · Reply
SuperGreenToday
SuperGreenToday Oct. 16 at 10:10 PM
$EW Share Price: $72.64 Contract Selected: Feb 20, 2026 $70 Calls Buy Zone: $4.76 – $5.88 Target Zone: $8.23 – $10.06 Potential Upside: 63% ROI Time to Expiration: 126 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 16 at 3:35 PM
Enter: $EW NOV 21 2025 $75 CALLS Buy in Price: $2.79 - $2.90 Take Profit: $4.32 Stop Bleeding: $2.46 ROI Potential: 55% Exit Within: 3 Weeks https://moneygroup.us/alerts
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 15 at 9:28 AM
Enter: $EW NOV 21 2025 $75 CALLS Buy in Price: $3.00 - $3.20 Take Profit: $4.89 Stop Bleeding: $2.64 ROI Potential: 63% Exit Within: 3 Weeks https://moneygroup.us/alerts
0 · Reply
roblake29
roblake29 Oct. 15 at 4:23 AM
$EW My latest article, on Edwards Lifesciences. I enjoyed working on this one. https://seekingalpha.com/article/4829891-edwards-lifesciences-inflection-incoming-but-when
0 · Reply
SuperGreenToday
SuperGreenToday Oct. 14 at 5:24 PM
$EW Share Price: $73.21 Contract Selected: Feb 20, 2026 $70 Calls Buy Zone: $6.46 – $7.98 Target Zone: $11.14 – $13.61 Potential Upside: 63% ROI Time to Expiration: 128 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply